• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


0.7402 USD 0.0504 6.37%

As of 20:10:00 ET on 09/17/2014.

Snapshot for GTx Inc (GTXI)

Open: 0.7600 Day's Range: 0.7300 - 0.8000 Volume: 535,726
Previous Close: 0.7906 52wk Range: 0.7300 - 2.3600 1-Yr Rtn: -61.04%

Stock Chart for GTXI

No chart data available.
  • GTXI:US 0.7400
  • 1D
  • 1M
  • 1Y
Interactive GTXI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GTXI

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5500
Est. EPS (USD) (12/2014) -0.4500
Est. PEG Ratio -
Market Cap (M USD) 56.27
Shares Outstanding (M) 76.01
30 Day Average Volume 205,503
Price/Book (mrq) 3.6811
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GTXI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GTXI

GTx, Inc. discovers, develops, and commercializes therapeutics primarily related to the treatment of serious men's health conditions. The Company's drug discover and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens, two essential classes of hormones. GTx is currently developing products for prostate cancer.

Marc S HanoverPresident/Interim CEO/COOHenry P DoggrellVP/Chief Legal Officer/Secy
Jeffrey G HesselbergVP:Regulatory AffairsMary Ann JohnstonVP:Medical Affairs
More Company Profile & Key Executives for GTXI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil